Phibro (PAHC): חובות להיוון בספרים

Phibro Animal Health is strengthening its position in veterinary medicine through partnerships with major agricultural holdings, creating safe feed solutions. In the vaccine segment, the company maintains high pricing power, although basic additives are limited by competition, and the metric stands at 2.18. The stock price trend reflects the dynamics of this business. Revenues rely on a moderately cyclical market, where drug procurement depends on raw material prices and farmer profits.

Capital structure distinguishes conservative business models from speculative ones by measuring the proportion of debt relative to the company's total balance sheet asset value. For Phibro Animal Health (PAHC), which relies on stable demand in veterinary medicine, the debt-to-market cap chart confirms financial stability, where low values minimize the risk of deep drawdowns, providing reliable protection for investments in the agri-science sector.